2004
DOI: 10.1016/j.jconrel.2004.04.003
|View full text |Cite
|
Sign up to set email alerts
|

Transdermal delivery of desmopressin using a coated microneedle array patch system

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

0
132
0
1

Year Published

2006
2006
2021
2021

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 150 publications
(134 citation statements)
references
References 23 publications
0
132
0
1
Order By: Relevance
“…The Macroflux system (Zosano Pharma, Fremont, CA) is a coated 2 cm 2 microneedle array composed of titanium that is being developed for delivery of a range of drugs and vaccines. [99][100][101] It has been used to deliver a target dose of 20 mg desmopressin within 15 min with 85% bioavailability. 99 This compares favourably with alternative delivery routes such as intranasal and oral administration which exhibit low and variable bioavailability.…”
Section: Stratum Corneum Physical Penetration-minimally Invasive Micrmentioning
confidence: 99%
“…The Macroflux system (Zosano Pharma, Fremont, CA) is a coated 2 cm 2 microneedle array composed of titanium that is being developed for delivery of a range of drugs and vaccines. [99][100][101] It has been used to deliver a target dose of 20 mg desmopressin within 15 min with 85% bioavailability. 99 This compares favourably with alternative delivery routes such as intranasal and oral administration which exhibit low and variable bioavailability.…”
Section: Stratum Corneum Physical Penetration-minimally Invasive Micrmentioning
confidence: 99%
“…[11][12][13][14][15][16][17][18][19] Microneedles are micron-scale needles that are produced by adapting the tools of the microelectronics industry and pierce across the stratum corneum and into the epidermis and/or superficial dermis to administer compounds into the skin for local or systemic administration. Microneedles can be assembled into patches, which offers simplicity of use and low cost similar to conventional transdermal patches.…”
Section: Introductionmentioning
confidence: 99%
“…Studies have shown that coated microneedles can carry a controlled dose by coating the drug only onto a defined region on the needle substrate surface. 14,15,20 The coated drug is released from the microneedle upon insertion into the skin. A drawback of this approach, however, is that such microneedles leave behind sharp, biohazardous waste after use, which may present safety concerns and special disposal needs.…”
Section: Introductionmentioning
confidence: 99%
“…22.2) [271]. Previous clinical and preclinical studies have also demonstrated the capability of their drug-coated microneedle patch technology to deliver peptides, recombinant proteins, and vaccine antigen [272][273][274][275].…”
Section: Microneedlesmentioning
confidence: 99%